Biogen, a Fortune 500 company, is the oldest independent biotech firm in the world esteemed for its cutting-edge therapies for a range of neurological disorders, such as multiple sclerosis. One of its biggest achievements over the years has been discovering one of the most prescribed treatments for non-Hodgkin lymphoma. The healthcare giant also created a groundbreaking medicine for rheumatoid arthritis. The company is determined to serve unmet medical needs and aims to be the most effective and admired company in the biopharmaceutical industry. It runs a range of patient support programmes and its core values are care and excellence.